Blog Read the latest perspectives from our team of subject matter experts and others How Incyte Is Advancing Clinical Trial DiversityDiversity in clinical trials is more than just a regulatory requirement—it’s a critical component of equitable healthcare. Ensuring that trial participants reflect the real-world patient population leads to more… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact HCP Volunteers KOL Engagement Patient Representation Provider Data Research Post Industries:Commercialization Global Impact Health Plans & Digital Health Pharmaceutical & Biotechnology Provider Data Research KOL EngagementThe Power of Micro-Influencers in HealthcareHow can we break through the noise to reach healthcare providers and key opinion leaders with important information? Consistently engaging external experts has always been one of the main… Continue reading → Read the article KOL EngagementDr. Krishna Aragam’s Impact on CardiologyScholarly Influence Publications Dr. Aragam is a Rising Star and Preventive Cardiologist at Massachusetts General Hospital as well as an Instructor of Medicine at Harvard Medical School. According to… Continue reading → Read the article KOL EngagementHow to Engage the Payer CommunityEven before COVID threw the entire healthcare ecosystem into disarray, payers as well as the healthcare market in general faced significant cost pressure. Healthcare payers reacted with consolidation and vertical… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Naveed Sattar’s ImpactScholarly Influence Publications Dr. Naveed Sattar is a top healthcare professional specializing in Endocrinology, Diabetes & Metabolism, and Cardiovascular Disease. He is renowned for his work in diabetes.… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Hugh Sampson’s ImpactPublications Scholarly Influence Dr. Hugh Sampson is an esteemed healthcare professional with a specialty in pediatric allergy and immunology. He is the Kurt Hirschhorn Professor of Pediatrics at the… Continue reading → Read the article Drug DevelopmentKOL Engagement9 Ways Medical Affairs Can Use Claims and Referral DataIn a recent interview an experienced medical affairs professional reminisced about the days when key opinion leader selection was a difficult and time consuming activity, which often relied on established… Continue reading → Read the article«‹11121314151617›»
